# Rituximab in Adult Acquired Idiopathic Thrombotic Thrombocytopenic Purpura

> **NCT00907751** · PHASE2 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 12 (actual)

## Conditions studied

- Thrombotic Thrombocytopenic Purpura

## Interventions

- **DRUG:** rituximab

## Key facts

- **NCT ID:** NCT00907751
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2014-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00907751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00907751, "Rituximab in Adult Acquired Idiopathic Thrombotic Thrombocytopenic Purpura". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00907751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*